Restitution at the cellular level: Regulation of the migrating phenotype

Yale Journal of Biology and Medicine

Volumn 69, Issue 2, 1996, Pages 119-129

  Basson, Marc D ^a   Rashid, Zaihan ^b   Turowski, Gregory A ^b   West, A Brian ^a   Emenaker, Nancy J ^b   Sgambati, Susan A ^b   Hong, Fu ^b   Perdikis, Demetrios M ^b   Datta, Sandeep ^b   Madri, Joseph A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Connecticut Vet Aff Hlth Care S ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASPARAGINE; BUTYRIC ACID; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CYTOSKELETON PROTEIN; DIPEPTIDYL PEPTIDASE; EPIDERMAL GROWTH FACTOR; GLUTAMINE; INTESTINE ENZYME; LAMININ; PENTAGASTRIN; PEPTIDE YY; PHORBOL 13 ACETATE 12 MYRISTATE; SCLEROPROTEIN; SUCRALFATE; VANADATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; NONHUMAN; PHENOTYPE; RAT;

ACTINS; ALKALINE PHOSPHATASE; ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN; DIPEPTIDYL PEPTIDASES; ENTEROSTOMY; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; EPITHELIUM; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL MUCOSA; INTESTINES; JEJUNUM; LAMININ; MEMBRANE PROTEINS; MICROVILLI; PENTAGASTRIN; PEPTIDE YY; PEPTIDES; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 12644256619     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Basson, M.D. Mucosal healing and adaptation in the small intestine. Curr. Opinion Gen. Surg. 2:138-146, 1994.
2. Moore, R., Carlson, S., and Madara, J. Rapid barrier restitution in an in vitro model of intestinal epithelial injury. Lab. Invest. 60:237-244, 1989.
3. Giebel, J., Thiedemann, K.U., and Schwenk, M. Gastric mucosal repair in vitro. J. Clin. Gastroenterology 13(Suppl. 1):S58-S64, 1991.
4. Yeomans, N.D. and Skeljo, M. V. Repair and healing of established gastric mucosal injury. J Clin Gastroenterology 13(Suppl. 1):S37-S41, 1991.
5. Feil, W., Lacey, E.R., Wong, Y.M., Burger, D., Wenzel, E., Starlinger, M., Schiessel, R. Rapid epithelial restitution of human and rabbit colonic mucosa. Gastroenterol. 97:685-701, 1989.
6. Tarnawski, A., Santos, A.M., Hanke, S., Stachura, J., Douglass, T.G., and Sarfeh, I.J. Quality of gastric ulcer healing. Is it influenced by antiulcer drugs? Scand. J. Gastroenterol. 208(Suppl. 1):9-13, 1995.
7. Schmassmann, A., Tarnawski, A., Gerber, H.A., Flogerzi, B., Sanner, M., Varga, L., and Halter, F. Antacid provides better restoration of glandular structures within the gastric ulcer scar than omeprazole. Gut 35:896-904, 1994
8. Peterson, M.D. and Mooseker, M.S. Characterization of the enterocyte-like brush border cytoskeleton of the CaCo2BBe clones of the human intestinal cell line, Caco-2. J. Cell Sci. 102:581-600, 1992.
9. Van Itallie, C.M., Balda, M.S, and Anderson, J.M. Epidermal growth factor induces tyrosine phosphorylation and reorganization of the tight junction protein ZO-1 in A431 cells. J. Cell Sci. 108:1735-42, 1995
10. Rink, T.J., Tsien, R.Y., and Pozzan, T. Cytoplasmic pH and free Mg in lymphocytes. J. Cell. Biol. 96:189-196, 1982.
11. Neguleseu, P.A., Reenstra, W.W., and Machen, T.E. Intracellular Ca requirements for stimulus-secretion coupling in parietal cells. Am. J. Phys. 256:C241-C251, 1989.
12. Bright, G.R., Fisher, G.W., Rogowska, J., and Taylor, D.L. Fluorescence ratio imaging microscopy. In: Methods in Cell Biology. Academic Press; 1989, Vol 30.
13. Madri, J.A., Pratt, B.M, and Yannariello-Brown, J. Matrix driven cell size changes modulate aortic endothelial cell proliferation and sheet migration. Am. J. Pathol. 132:18-27, 1988.
14. Basson, M.D., Modlin, I.M., and Madri, JA. Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor. J. Clin. Invest. 90:15-23, 1992.
15. Turowski, G.A., Rashid, Z., Hong, F., Madri, J.A., and Basson, M.D. Glutamine modulates phenotype and stimulates proliferation in human colon cancer cell lines. Canc. Res. 54:5974-5980, 1994.
16. Basson, M.D., Turowski, G., and Emenaker, N.J. Regulation of human (Caco-2) differentiation by extracellular matrix proteins. Exp. Cell Res. 225:301-305, 1996.
17. Basson, M.D., Hong, F., and Emenaker, N.J. Specific modulation of intestinal epithelial brush border enzyme expression by a phorbol ester. J. Surg. Res. 59:121-126, 1995.
18. Madri, J.A. and Basson, M.D. Extracellular matrix: cell interactions: Dynamic modulators of cell, tissue and organism structure and function. Lab Invest. 66:519-521, 1992.
19. Basson, M.D. and Hong, F. The metabolites of different dietary fibers exert distinct effects on human (Caco-2) colonocytes. Surg. Forum. 45:192-194, 1994.
20. Sgambati, S., Turowski, G.A., and Basson, M.D. PYY selectively promotes expression of the colonocytic phenotype and stimulates proliferation of a human intestinal epithelial stem cell model. Surg. Forum. 46:179-182, 1995.
21. Basson, M.D. and Hong, F. Modulation of human Caco-2 intestinal epithelial cell phenotype by protein kinase C inhibitors. Cell Biol. Int. 19:1025-1032, 1995.
22. Basson, M.D. and Hong, F. Regulation of human Caco-2 intestinal epithelial brush border enzyme activity by cyclic nucleotides. Canc. Lettr. 99:155-160, 1996.
23. Basson, M.D., Beidler, D.R., Turowski, G., Zarif, A., Modlin, I.M., Jena, B.P., and Madri, J.A. The effects of tyrosine kinase inhibition on basal and EGF-stimulated Caco-2 enterocyte sheet migration and proliferation. J. Cell Phys. 160:491-501, 1994.
24. Datta, S., Emenaker, N.J., and Basson, M.D. Sucralfate inhibits intestinal mucosal wound healing in a cell culture model. Surg. Forum. 46:714-716, 1995.
25. Kurihara, H., Andersen, J.M., and Farquhar, M.G. Increased Tyr phosphorylation of ZO-1 during modification of tight junctions between glomerular foot processes. Am. J. Physiol. 268:F514-24, 1995.
26. Buse, P., Woo, P.L., Alexander, D.B., Cha, H.H., Reza, A., Sirota, N.D., and Firestone, G.L. Transforming growth factor-alpha abrogates glucocorticoid-stimulated tight junction formation and growth suppression in rat mammary epithelial tumor cells. J. Biol. Chem. 24;:6505-14, 1995.
27. Watabe, M., Nagafuchi, A., Tsukita, S., and Takeichi, M. Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J. Cell Biol. 127:247-56, 1994.
28. Nagashima, R. Development of and characteristics of sucralfate. J. Clin. Gastroenterol. 3 (Suppl. 2):103-110, 1981.
29. Tarnawski, A., Hollander, D., and Gergely, H. The mechanism of protective, therapeutic, and prophylactic actions of sucralfate. Scand J Gastroenterol 140(Suppl):7-13, 1987.
30. Hollander, D. Peptic disease treatment: sucralfate and cytoprotection in the 1980s. Am. J .Med. 86:152-153, 1989.
31. Folkman, J., Szabo, S, Stovroff, M., McNeil, P., Li, W., and Shing, Y. Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann. Surg. 214: 414-425, 1991.
32. Korman, M.G., Bolin, T.D., Szabo, S., Hunt, R.H., Marks, I.N., and Glise, H. Sucralfate: the Bangkok review. J. Gastroenterol. Hepatol. 9:412-415, 1994 .
33. Emenaker, N.J., Datta, S., and Basson, M.D. Sucralfate impedes intestinal epithelial sheet migration in a Caco-2 cell culture model. Digestion (In press).